CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 8-K Event Regulation FD disclosure · Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4/A Open-market sale Chief Development Officer sold 11,537 shares at $3.16 ($36,503)
- 4/A Open-market sale See Remarks sold 13,201 shares at $3.41 ($44,968)
- 4 Open-market buy 10% owner bought 177,993 shares at an average $4.68 ($833,867)
- 4 Open-market buy 10% owner bought 504,272 shares at an average $3.84 ($1,934,505)
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale See Remarks sold 13,201 shares at $3.41 ($44,968)
- 4 Open-market sale Chief Development Officer sold 29,768 shares at an average $3.31 ($98,605)
- 4 Open-market sale President and CEO sold 183,238 shares at an average $3.17 ($580,760)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-3 Offering Registration Statement
Page 6 of 33 · 650 filings